Related Experiment Video
Updated: Feb 11, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Anisomycin prevents OGD-induced necroptosis by regulating the E3 ligase CHIP
Mi-Bo Tang1,2, Yu-Sheng Li1, Shao-Hua Li1,2
1Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450000, Henan, China.
Abstract:
Necroptosis is an essential pathophysiological process in cerebral ischemia-related diseases. Therefore, targeting necroptosis may prevent cell death and provide a much-needed therapy. Ansiomycin is an inhibitor of protein synthesis which can also activate c-Jun N-terminal kinases. The present study demonstrated that anisomycin attenuated necroptosis by upregulating CHIP (carboxyl terminus of Hsc70-interacting protein) leading to the reduced levels of receptor-interacting protein kinase 1 (RIPK1) and receptor-interacting protein kinase 3 (RIPK3) proteins in two in vitro models of cerebral ischemia. Further exploration in this research revealed that losing neither the co-chaperone nor the ubiquitin E3 ligase function of CHIP could abolish its ability to reduce necroptosis. Collectively, this study identifies a novel means of preventing necroptosis in two in vitro models of cerebral ischemia injury through activating the expression of CHIP, and it may provide a potential target for the further study of the disease.
Insights
Anisomycin treatment reduces necroptosis, a cell death process in brain injury, by increasing CHIP protein. This finding offers a new therapeutic target for cerebral ischemia.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Necroptosis is a key process in brain injuries like cerebral ischemia.
- Targeting necroptosis offers a potential therapeutic strategy to prevent cell death.
Purpose of the Study:
- To investigate the effect of anisomycin on necroptosis in in vitro models of cerebral ischemia.
- To elucidate the role of carboxyl terminus of Hsc70-interacting protein (CHIP) in anisomycin-mediated attenuation of necroptosis.
Main Methods:
- Utilized two in vitro models of cerebral ischemia.
- Administered anisomycin, a protein synthesis inhibitor and c-Jun N-terminal kinase activator.
- Assessed protein levels of receptor-interacting protein kinase 1 (RIPK1) and receptor-interacting protein kinase 3 (RIPK3).
- Investigated the necessity of CHIP's co-chaperone and ubiquitin E3 ligase functions.
Main Results:
- Anisomycin attenuated necroptosis in both cerebral ischemia models.
- Anisomycin upregulated CHIP expression, leading to reduced RIPK1 and RIPK3 protein levels.
- CHIP's ability to reduce necroptosis was independent of its co-chaperone and ubiquitin E3 ligase functions.
Conclusions:
- Activating CHIP expression represents a novel strategy to prevent necroptosis in cerebral ischemia.
- CHIP modulation offers a potential therapeutic target for treating cerebral ischemia-related diseases.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
GTPases and their Regulation
Large G-proteins,...
Epigenetic Regulation
Cancer Prevention
Some...
Master Transcription Regulators
Negative Regulator Molecules

